CNXC
Concentrix Corp
Concentrix Corp historical holders
total: 3
Tweedy, Browne Co All Funds (US) Concentrix Corp transactions over time
- Total transactions:
- 22
- New positions:
- 1
- Added:
- 3
- Reduced:
- 18
- Held since:
- 2020 Q4
- Held for:
- 22 quarters
- Latest activity:
- 2026 Q1
Tweedy, Browne Co All Funds (US) has been an institutional investor in Concentrix Corp (CNXC) since 2020 Q4. According to 2026 Q1 report, Tweedy, Browne Co All Funds (US) holds 13,623 shares with a market value of roughly $372.72K representing 0.03% of their equity portfolio. The fund/company first acquired CNXC in 2020 Q4, initially purchasing 71,717 shares. Since the initial investment, Tweedy, Browne Co All Funds (US) has made 21 more transactions in this position.
Does Tweedy, Browne Co All Funds (US) still hold CNXC?
Yes, Tweedy, Browne Co All Funds (US) continues to hold Concentrix Corp (CNXC). According to their 2026 Q1 report, they maintain a position of 13,623 shares valued at approximately $372.72K, representing 0.03% of their equity portfolio.
When did Tweedy, Browne Co All Funds (US) first invest in CNXC?
Tweedy, Browne Co All Funds (US) first invested in Concentrix Corp (CNXC) in 2020 Q4 at the reported quarter-end price of $98.69 per share, acquiring 71,717 shares in their initial purchase.
What is Tweedy, Browne Co All Funds (US)'s average cost basis for CNXC?
Based on historical transaction data, Tweedy, Browne Co All Funds (US)'s estimated cost basis for Concentrix Corp (CNXC) is approximately $109.48 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $109.48
- Weighted AVG sell price:
- $94.11
CNXC transactions history by Tweedy, Browne Co All Funds (US)
22 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.03%
|
13,623
|
$27.36
|
$372,725
|
-2.50% (-350)
|
-0%
|
|
2025 Q4
|
0.05%
|
13,973
|
$41.58
|
$580,997
|
-1.31% (-185)
|
-0%
|
|
2025 Q3
|
0.06%
|
14,158
|
$46.15
|
$653,392
|
-4.71% (-700)
|
-0%
|
|
2025 Q2
|
0.07%
|
14,858
|
$52.86
|
$785,320
|
-32.62% (-7,193)
|
-0.03%
|
|
2025 Q1
|
0.11%
|
22,051
|
$55.64
|
$1,226,918
|
-21.82% (-6,156)
|
-0.02%
|
|
2024 Q4
|
0.08%
|
28,207
|
$43.27
|
$1,220,517
|
-82.82% (-135,998)
|
-0.28%
|
|
2024 Q3
|
0.40%
|
164,205
|
$51.25
|
$8,415,506
|
-1.27% (-2,118)
|
-0%
|
|
2024 Q2
|
0.48%
|
166,323
|
$63.28
|
$10,524,919
|
-4.05% (-7,015)
|
-0.02%
|
|
2024 Q1
|
0.54%
|
173,338
|
$66.22
|
$11,478,442
|
+21.61% (+30,798)
|
+0.1%
|
|
2023 Q4
|
0.68%
|
142,540
|
$98.21
|
$13,998,853
|
-4.06% (-6,031)
|
-0.03%
|
|
2023 Q3
|
0.64%
|
$80.11
|
-33.30% (-74,182)
|
|||
|
2023 Q2
|
0.94%
|
$80.75
|
-19.33% (-53,359)
|
|||
|
2023 Q1
|
1.83%
|
$121.55
|
-0.61% (-1,699)
|
|||
|
2022 Q4
|
1.97%
|
$133.16
|
-44.92% (-226,542)
|
|||
|
2022 Q3
|
2.48%
|
$111.63
|
+444.30% (+411,693)
|
|||
|
2022 Q2
|
0.51%
|
$135.64
|
-1.08% (-1,014)
|
|||
|
2022 Q1
|
0.50%
|
$166.56
|
-1.42% (-1,345)
|
|||
|
2021 Q4
|
0.54%
|
$178.62
|
-1.18% (-1,135)
|
|||
|
2021 Q3
|
0.57%
|
$177.00
|
-1.50% (-1,468)
|
|||
|
2021 Q2
|
0.44%
|
$160.80
|
-4.38% (-4,470)
|
|||
|
2021 Q1
|
0.44%
|
$149.72
|
+42.35% (+30,375)
|
|||
|
2020 Q4
|
0.22%
|
$98.69
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.